hansoh glp 1 REAL-WORLD EVIDENCE OF GLP-1RAS PUBLISHED IN AN INTERNATIONAL JOURNAL REVEALS BETTER OPTION PHARMA'S FULAIMEI PROVIDES FOR DKD PATIENTS-Press Releases-Hansoh Pharmaceutical Group Co., Ltd Merck Enters into Exclusive Global

They are generally not recommended for patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), those who are pregnant or breastfeeding or planning pregnancy, patients with a known allergy to the medication, severe gastroparesis or serious digestive motility disorders, active pancreatitis or significant pancreatitis history, serious gallbladder disease, certain kidney conditions, or active eating disorder concerns

GLP-1 medications are typically considered for adults who: Have a Body Mass Index (BMI) of 30 or higher Have a BMI of 27 or higher with weight-related conditions such as diabetes or hypertension Have not achieved sustained weight loss through lifestyle modification alone These medications are intended for long-term weight management, not short-term or cosmetic weight loss

Diabetes 16 , e70014 (2024)

In December 2025, Winfrey told People that she went off the medication for a year because she wanted to prove that she could "do without it," but ended up gaining 20 pounds

Membrane separation systems not only precisely separate the target product but also recover and concentrate these valuable materials for reuse, thereby directly reducing material consumption costs per unit of output and yielding particularly significant economic benefits